Cybin Inc. (OTCMKTS:CLXPF – Get Free Report)’s stock price traded up 5.7% during mid-day trading on Friday . The company traded as high as $6.00 and last traded at $5.95. 644,862 shares traded hands during trading, an increase of 17% from the average session volume of 551,962 shares. The stock had previously closed at $5.63.
Cybin Price Performance
The stock has a market capitalization of $890.10 million and a P/E ratio of -42.79. The stock has a 50 day moving average price of $6.17 and a 200-day moving average price of $7.01.
Cybin Company Profile
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
Further Reading
- Five stocks we like better than Cybin
- The Basics of Support and Resistance
- Five Below and Dollar Tree Earnings Signal a Shopper Shift
- How to buy stock: A step-by-step guide for beginners
- Ulta’s Stock May Be Set for a Glow-Up—20% Upside Ahead?
- 3 Defense Stocks Set to Benefit From Increased Military Spending
- Gates Foundation Sells MSFT Stock—Should Investors Be Worried?
Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.
